Dennis B, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P
J Subst Use Addict Treat. 2024; 167():209524.
PMID: 39341602
PMC: 11750131.
DOI: 10.1016/j.josat.2024.209524.
Demirchyan A, Mozalevskis A, Sahakyan S, Musheghyan L, Aslanyan L, Muradyan D
Viruses. 2024; 16(9).
PMID: 39339922
PMC: 11437486.
DOI: 10.3390/v16091446.
Rzymski P, Brzdek M, Dobrowolska K, Poniedzialek B, Murawska-Ochab A, Zarebska-Michaluk D
Viruses. 2024; 16(9).
PMID: 39339862
PMC: 11435954.
DOI: 10.3390/v16091386.
Kamili S, Wester C
J Infect Dis. 2024; 229(Supplement_3):S313-S315.
PMID: 38466750
PMC: 11078305.
DOI: 10.1093/infdis/jiae127.
Alarcon J, Dao B, Santos M, Jewell M, Donabedian C, Stanley A
Infect Control Hosp Epidemiol. 2024; 45(4):549-550.
PMID: 38268342
PMC: 11110885.
DOI: 10.1017/ice.2023.294.
Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity.
Pinheiro P, Jones P, Medina H, Cranford H, Koru-Sengul T, Bungum T
Clin Gastroenterol Hepatol. 2023; 22(3):562-571.e8.
PMID: 37678486
PMC: 10915102.
DOI: 10.1016/j.cgh.2023.08.016.
Hepatitis C Treatment in Persons Who Inject Drugs in a Medication Assisted Treatment Program: A Retrospective Review of an Integrated Model.
Bobb R, Malayala S, Ajayi E, Wimbush A, Bobb A
J Prim Care Community Health. 2023; 14:21501319231164884.
PMID: 37005793
PMC: 10074636.
DOI: 10.1177/21501319231164884.
The signal-to-cutoff ratios to predict HCV infection among people who inject drugs.
Chen B, Gao L, Ma Z, Chang H, Pei L, Zhou Q
Virusdisease. 2022; 33(4):363-370.
PMID: 36278030
PMC: 9579682.
DOI: 10.1007/s13337-022-00797-5.
Mental Illness in Adults With HIV and HCV Infection: Indian Health Service, 2001-2020.
Smith C, Kennedy J, Evans M, Person M, Haverkate R, Apostolou A
Am J Prev Med. 2022; 63(3):e77-e86.
PMID: 35589441
PMC: 9887638.
DOI: 10.1016/j.amepre.2022.03.023.
Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.
Facente S, Grinstein R, Bruhn R, Kaidarova Z, Wilson E, Hecht J
PLoS One. 2022; 17(5):e0267902.
PMID: 35544483
PMC: 9094540.
DOI: 10.1371/journal.pone.0267902.
The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis.
Moradi G, Soheili M, Rashti R, Dehghanbanadaki H, Nouri E, Zakaryaei F
Eur J Med Res. 2022; 27(1):47.
PMID: 35346371
PMC: 8962539.
DOI: 10.1186/s40001-022-00677-0.
Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.
Moore M, Bocour A
Public Health Rep. 2021; 137(6):1126-1135.
PMID: 34694921
PMC: 9574298.
DOI: 10.1177/00333549211049263.
Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017.
Wingate H, Sizemore L, Black J, Heth Z, Talley P, Patrick S
Public Health Rep. 2021; 137(5):860-866.
PMID: 34404285
PMC: 9379847.
DOI: 10.1177/00333549211035854.
Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016).
Nikiforuk A, Karim M, Patrick D, Jassem A
BMC Public Health. 2021; 21(1):1388.
PMID: 34256707
PMC: 8278694.
DOI: 10.1186/s12889-021-11267-w.
Hepatitis C Treatment Knowledge and Practice Among Family Medicine Physicians in Wisconsin During the Current Hepatitis C Epidemic.
Koepke R, Akhtar W, Kung V, Seal D, Salisbury-Afshar E, Westergaard R
WMJ. 2021; 120(2):106-113.
PMID: 34255949
PMC: 9595867.
Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications.
Park J, Wong J, Cohen H
PLoS One. 2021; 16(6):e0252976.
PMID: 34111200
PMC: 8191914.
DOI: 10.1371/journal.pone.0252976.
Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic.
Kaufman H, Bull-Otterson L, Meyer 3rd W, Huang X, Doshani M, Thompson W
Am J Prev Med. 2021; 61(3):369-376.
PMID: 34088556
PMC: 8107198.
DOI: 10.1016/j.amepre.2021.03.011.
The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018.
Holtzman D, Asher A, Schillie S
Am J Public Health. 2021; 111(5):949-955.
PMID: 33734844
PMC: 8034015.
DOI: 10.2105/AJPH.2020.306149.
Quantitative differences between intra-host HCV populations from persons with recently established and persistent infections.
Icer Baykal P, Lara J, Khudyakov Y, Zelikovsky A, Skums P
Virus Evol. 2021; 7(1):veaa103.
PMID: 33505710
PMC: 7816669.
DOI: 10.1093/ve/veaa103.
Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system.
Javanbakht M, Archer R, Klausner J
PLoS One. 2020; 15(11):e0241615.
PMID: 33147293
PMC: 7641373.
DOI: 10.1371/journal.pone.0241615.